- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
114 CHAPTER 4 Incontinence
Evaluation
History
Inquire about LUTS (storage or voiding symptoms), triggers for incontinence (cough, sneezing, exercise, position, urgency), and frequency and severity of symptoms. Establish risk factors (abdominal/pelvic surgery; neurological diseases; obstetric and gynecological history; medications).
A validated patient-completed questionnaire may be helpful (e.g., IPSS; see Fig. 1.1, p. 11).
Physical examination
Women
Perform a pelvic examination in the supine and standing position with a speculum while the patient has a full bladder. Ask the patient to cough or strain, and inspect for vaginal wall prolapse (cystocele, rectocele, enterocele), uterine or perineal descent, and urinary leakage (stress test). Eighty percent of SUI patients will leak with a brief squirt during cough in the supine position, while another 20% will leak only in an inclined or standing position.
Urethral hypermobility is assessed with the Q-tip test. A lubricated cot- ton-tipped applicator is introduced through the urethra to bladder neck level. Hypermobility is defined as a resting or straining angle of >30* from horizontal.
The Bonney test is used to assess continence with manual repositioning of the urethra and vesicle neck. Using one or two fingers to elevate the anterior vaginal wall laterally without compressing the urethra, relief of incontinence during cough suggests that surgical correction will be successful.
Both sexes
Examine the abdomen for a palpable bladder (indicating urinary retention). A neurological examination should include assessment of anal tone and reflex, perineal sensation, and lower limb function.
Inspect the underwear for the status of urinary collection pads; for men, a standing or squatting “cough test” gives a good indicator of the presence and severity of stress incontinence.
Investigation
Bladder diaries
Record the frequency and volume of urine voided, incontinent episodes, pad usage, fluid intake, and degree of urgency. Alternatively, pads can be weighed to estimate urine loss (pad testing).
Urinalysis can exclude UTIs.
Blood tests, X-ray imaging, cystoscopy
These are indicated for persistent or severe symptoms, bladder pain, and voiding difficulties. Cystoscopy is useful for evaluating men who have had prostatectomy—it will show the presence of clips, stones, and strictures that may develop after surgery that might need to be addressed concomitantly with anti-incontinence surgery.
EVALUATION 115
Screening tests
Uroflow testing measures the ability of the bladder to empty; a minimum bladder volume of 150 cc is desired. A low flow rate indicates bladder outflow obstruction or reduced bladder contractility. The volume of urine remaining in the bladder after voiding (post-void residual) is also important (<50 mL is normal; >200 mL is abnormal; 50–200 mL requires clinical correlation).
Urodynamic investigations
Valsalva leak point pressure (VLPP) measures the abdominal pressure at which a half-full bladder leaks during straining—normal individuals should not leak. VLPP readings <60 cm H2O suggest ISD; VLPP readings >100 cm H2O suggest hypermobility, while readings of 60–100 cm are indeterminant.
Detrusor leak point pressure (DLPP) measures the bladder pressure at which leakage occurs without valsalva—DLPP >40 cm H2O puts the upper tract at risk.
Videourodynamics can visualize movement of the proximal urethra and bladder neck, and establish the precise anatomical etiology of UI.
Sphincter electromyography (EMG)
EMG measures electrical activity from striated muscles of the urethra or perineal floor and provides information on synchronization between bladder muscle (detrusor) and external sphincter.
116 CHAPTER 4 Incontinence
Treatment of sphincter weakness incontinence: injection therapy
The injection of bulking materials into the bladder neck and periurethral muscles is used to increase outlet resistance. Bulking substances include silicone polymers (Macroplastique); cross-linked bovine collagen (Contigen); Teflon; PTFE; and carbon-coated zirconium beads (Durasphere).
Indications
These include stress incontinence secondary to demonstrable intrinsic sphincter deficiency (ISD), with normal bladder muscle function. Injection therapy is used in adults and children.
Contraindications
These include UTI, untreated bladder dysfunction, and bladder neck stenosis. There is improved outcome in patients without urethral hypermobility (which is better treated with a sling or, less commonly, an artificial urinary sphincter).
Preinjection evaluation
Conduct a stress test and Q-tip test. Use videourodynamics to diagnose ISD and exclude detrusor overactivity.
Injection techniques
Either a local block or a general anesthetic is required, with full antibiotic coverage. Usually a series of injections are given via a transurethral (retrograde) route using a cystoscopically guided injection needle. The bulking agent is injected suburethrally with the aim of achieving urethral muscosal apposition and closure of the lumen.
In men, injection treatment following radical prostatectomy is associated with success rates <10%. In women, a periurethral (percutaneous) technique can also be used, with endoscopic or ultrasound guidance: overall success rate in women is ~50–70%.1,2
Complications
Complications include urinary urgency, urinary retention (which may need ISC or SPC insertion), hematuria, cystitis, migration of the injected particles (PTFE, Macroplastique), and risk of granuloma formation (PTFE). Repeat treatments are the norm.
1 Koelbl H (1998). Transurethral injection of silicone microimplants for intrinsic urethral sphincter deficiency. Obstet Gynaecol 92:332–336.
2 Appell RA (1994). Collagen injection therapy for urinary incontinence. Urol Clin North Am 21:177–182.
TREATMENT OF SPHINCTER WEAKNESS INCONTINENCE 117
Treatment of sphincter weakness incontinence: retropubic suspension
Retropubic suspension procedures are used to treat female stress incontinence caused by urethral hypermobility. The aim of surgery is to elevate and fix the bladder neck and proximal urethra in a retropubic position, to support the bladder neck, and to regain continence.
It is contraindicated in the presence of significant intrinsic sphincter deficiency (ISD).
Types of surgery
Surgery is considered after conservative methods have failed. The main types of operation are via a Pfannenstiel or lower midline abdominal incision to approach the bladder neck and develop the retropubic space. Better results are seen in patients with pure stress incontinence and primary repair (as opposed to “redo” surgery).
Marshall–Marchetti–Krantz (MMK) procedure
Sutures are placed either side of the urethra around the level of the bladder neck and then tied to the hyaline cartilage of the pubic symphysis. Short-term success is about 90%,1 but declines over time.
Complications include osteitis pubis (3%), typically presenting up to 8 weeks postoperatively, with pubic pain radiating to the thigh. Treatment is with simple analgesia, bed rest, and steroids.
Burch colposuspension
This requires good vaginal mobility, to allow the vaginal wall to be elevated and attached to the lateral pelvic wall where the formation of adhesions over time secures its position. The paravaginal fascia is exposed and approximated to the iliopectineal (Cooper) ligament of the superior pubic rami.
Initial success rates are 90%.1 Better long-term results compare with those for other retropubic repairs. A laparoscopic approach can also be performed, but long-term results have proven to be poor.
Vagino-obturator shelf/paravaginal repair
Sutures are placed by the vaginal wall and paravaginal fascia and then passed through the obturator fascia to attach to part of the parietal pelvic fascia below the tendinous arch (arcus tendoneus fascia). Cure rates are up to 85%.
Complications of retropubic suspension procedures
•Urinary retention (5%)
•Bladder overactivity
•Vaginal prolapse
1 Jarvis GJ (1994). Stress incontinence. In Mundy AR, Stephenson TP, Wein AJ (Eds.), Urodynamics: Principles, Practice and Application, 2nd ed. New York: Churchill-Livingstone, pp. 299–326.